Global Expansion Proceeds, now into the U.S.:
Long-term accomplished founder and management have shepherded SBC from a solo clinic in 2000 to become a global cosmetic treatment center franchiser and cash generation machine with little debt. However, revenue growth has declined in recent quarters yoy (which is expected to persist into early-2026), reflecting increased market competition pressure. Revenue growth has stabilized sequentially in Q3:25, though. Looking through the valley sees the Company growing again in early-2026 with prospects for global M&A in addition to opportunistic Japanese M&A. To that end, the Company has announced a new strategic minority equity investment and collaboration framework with Orange Twist in the U.S., following a prudent phased global M&A process.
